Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Work In Process (2020 - 2022)

Historic Work In Process for Rapid Micro Biosystems (RPID) over the last 3 years, with Q2 2022 value amounting to $722000.0.

  • Rapid Micro Biosystems' Work In Process rose 27.78% to $722000.0 in Q2 2022 from the same period last year, while for Jun 2022 it was $722000.0, marking a year-over-year increase of 27.78%. This contributed to the annual value of $1.2 million for FY2021, which is 378.15% up from last year.
  • According to the latest figures from Q2 2022, Rapid Micro Biosystems' Work In Process is $722000.0, which was up 27.78% from $873000.0 recorded in Q1 2022.
  • Rapid Micro Biosystems' 5-year Work In Process high stood at $1.2 million for Q4 2021, and its period low was $689000.0 during Q3 2021.
  • For the 3-year period, Rapid Micro Biosystems' Work In Process averaged around $904833.3, with its median value being $797500.0 (2022).
  • As far as peak fluctuations go, Rapid Micro Biosystems' Work In Process skyrocketed by 378.15% in 2021, and later grew by 27.78% in 2022.
  • Over the past 3 years, Rapid Micro Biosystems' Work In Process (Quarter) stood at $1.2 million in 2020, then rose by 3.78% to $1.2 million in 2021, then tumbled by 41.54% to $722000.0 in 2022.
  • Its Work In Process was $722000.0 in Q2 2022, compared to $873000.0 in Q1 2022 and $1.2 million in Q4 2021.